BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fibrosis
1
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 19 | Download: 1
2
Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
11/24/2020 12:41:21 PM | Browse: 130 | Download: 213
3
Efficacy and safety of anti-hepatic fibrosis drugs
11/6/2020 7:36:12 AM | Browse: 149 | Download: 246
4
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 244 | Download: 293
5
Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis
6/6/2020 2:43:56 PM | Browse: 279 | Download: 327
6
Macrophages in metabolic associated fatty liver disease
4/28/2020 8:04:30 AM | Browse: 257 | Download: 222
7
Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
1/16/2020 7:58:40 AM | Browse: 297 | Download: 491
8
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 362 | Download: 467
9
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
9/7/2019 4:43:36 AM | Browse: 384 | Download: 546
10
Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
8/21/2019 9:19:18 AM | Browse: 407 | Download: 567
11
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 349 | Download: 289
12
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 386 | Download: 516
13
Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
5/27/2019 8:24:36 AM | Browse: 372 | Download: 404
14
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
4/26/2019 3:40:00 AM | Browse: 409 | Download: 387
15
Repurposing drugs to target nonalcoholic steatohepatitis
4/18/2019 5:48:09 AM | Browse: 487 | Download: 431
16
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
3/27/2019 10:37:20 AM | Browse: 455 | Download: 664
17
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 541 | Download: 653
18
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 502 | Download: 446
19
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 546 | Download: 474
20
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 519 | Download: 504
21
Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study
1/26/2019 8:24:19 AM | Browse: 380 | Download: 444
22
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 605 | Download: 520
23
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 376 | Download: 321
24
Management of local recurrence after endoscopic resection of neoplastic colonic polyps
12/21/2018 6:09:14 AM | Browse: 442 | Download: 501
25
Liver as a target of human immunodeficiency virus infection
11/13/2018 8:04:45 AM | Browse: 523 | Download: 482
26
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
10/18/2018 10:13:24 AM | Browse: 441 | Download: 468
27
A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
9/7/2018 9:21:44 AM | Browse: 505 | Download: 540
28
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report
9/7/2018 1:56:18 AM | Browse: 449 | Download: 423
29
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 551 | Download: 632
30
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 666 | Download: 540
31
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 672 | Download: 365
32
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
4/27/2018 3:25:40 AM | Browse: 658 | Download: 448
33
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 595 | Download: 474
34
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 731 | Download: 620
35
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
3/16/2018 12:27:25 PM | Browse: 629 | Download: 474
36
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease
1/26/2018 8:09:36 AM | Browse: 614 | Download: 532
37
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 724 | Download: 602
38
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
1/14/2018 5:07:58 AM | Browse: 726 | Download: 478
39
Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells
1/14/2018 5:07:58 AM | Browse: 634 | Download: 478
40
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 639 | Download: 549
41
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 670 | Download: 479
42
Pathological process of liver sinusoidal endothelial cells in liver diseases
11/20/2017 4:03:35 AM | Browse: 721 | Download: 499
43
Risk of liver disease in methotrexate treated patients
9/15/2017 5:43:48 AM | Browse: 657 | Download: 677
44
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
9/13/2017 7:36:12 AM | Browse: 573 | Download: 746
45
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
9/7/2017 2:39:18 AM | Browse: 601 | Download: 812
46
Fibrinogen deficiency suppresses the development of early and delayed radiation enteropathy
7/12/2017 6:45:23 AM | Browse: 584 | Download: 639
47
Impact of hepatitis C oral therapy in portal hypertension
7/12/2017 6:45:23 AM | Browse: 654 | Download: 935
48
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
6/26/2017 10:23:06 AM | Browse: 635 | Download: 744
49
Cardiac damage in athlete’s heart: When the “supernormal” heart fails!
6/26/2017 12:49:43 AM | Browse: 597 | Download: 443
50
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 633 | Download: 914